» Articles » PMID: 32153365

Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an IPSC-Derived 3D Human Brain Model

Abstract

Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy. Various concerns have been raised about the possible effects of these drugs on fetal development. Current developmental neurotoxicity (DNT) testing conducted in rodents is expensive, time-consuming, and does not necessarily represent human pathophysiology. A human, testing battery to cover key events of brain development, could potentially overcome these challenges. In this study, we assess the DNT of paroxetine-a widely used SSRI which has shown contradictory evidence regarding effects on human brain development using a versatile, organotypic human induced pluripotent stem cell (iPSC)-derived brain model (BrainSpheres). At therapeutic blood concentrations, which lie between 20 and 60 ng/ml, Paroxetine led to an 80% decrease in the expression of synaptic markers, a 60% decrease in neurite outgrowth and a 40-75% decrease in the overall oligodendrocyte cell population, compared to controls. These results were consistently shown in two different iPSC lines and indicate that relevant therapeutic concentrations of Paroxetine induce brain cell development abnormalities which could lead to adverse effects.

Citing Articles

Anticholinergic drugs and dementia risk: Using stem cell-based studies to complement pharmacoepidemiology.

Schwarze-Taufiq T, Pranoto I, Hui K, Kinoshita C, Yu O, Crane P Alzheimers Dement (N Y). 2025; 11(1):e70040.

PMID: 39911736 PMC: 11795422. DOI: 10.1002/trc2.70040.


Curcumin and exercise prevent depression alleviating hippocampus injury and improve depressive-like behaviors in chronically stressed depression rats.

Ahmadi E, Pourmotabbed A, Aghaz N, Nedaei S, Veisi M, Salimi Z Res Pharm Sci. 2024; 19(5):509-519.

PMID: 39691296 PMC: 11648346. DOI: 10.4103/RPS.RPS_94_23.


Medicinal plants and plant-based traditional medicine: Alternative treatments for depression and their potential mechanisms of action.

Remali J, Aizat W Heliyon. 2024; 10(20):e38986.

PMID: 39640650 PMC: 11620067. DOI: 10.1016/j.heliyon.2024.e38986.


Assessing the Neurodevelopmental Impact of Fluoxetine, Citalopram, and Paroxetine on Neural Stem Cell-Derived Neurons.

Hosseini K, Cediel-Ulloa A, Al-Sabri M, Forsby A, Fredriksson R Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39459031 PMC: 11510426. DOI: 10.3390/ph17101392.


The use of induced pluripotent stem cells as a platform for the study of depression.

Villafranco J, Martinez-Ramirez G, Magana-Maldonado R, Gonzalez-Ruvalcaba A, Lopez-Ornelas A, Velasco I Front Psychiatry. 2024; 15:1470642.

PMID: 39444629 PMC: 11496182. DOI: 10.3389/fpsyt.2024.1470642.


References
1.
Douvaras P, Wang J, Zimmer M, Hanchuk S, OBara M, Sadiq S . Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells. Stem Cell Reports. 2014; 3(2):250-9. PMC: 4176529. DOI: 10.1016/j.stemcr.2014.06.012. View

2.
Valenti O, Di Prima F, Renda E, Faraci M, Hyseni E, De Domenico R . Fetal cardiac function during the first trimester of pregnancy. J Prenat Med. 2012; 5(3):59-62. PMC: 3279166. View

3.
Ellfolk M, Malm H . Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs). Reprod Toxicol. 2010; 30(2):249-60. DOI: 10.1016/j.reprotox.2010.04.015. View

4.
Hale T, Kendall-Tackett K, Cong Z, Votta R, McCurdy F . Discontinuation syndrome in newborns whose mothers took antidepressants while pregnant or breastfeeding. Breastfeed Med. 2010; 5(6):283-8. DOI: 10.1089/bfm.2010.0011. View

5.
Bal-Price A, Coecke S, Costa L, Crofton K, Fritsche E, Goldberg A . Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. ALTEX. 2012; 29(2):202-15. DOI: 10.14573/altex.2012.2.202. View